There have been numerous studies that ques‑
tioned the safety of acid suppression, particular‑
ly from PPI therapy, also in the hospital setting.
To some degree, those concerns may be applica‑
ble to the critically ill population. Studies suggest
that PPI therapy may be associated with increased risk of hospital acquired pneumonia